ReNeuron

100 articles about ReNeuron

• ReNeuron Announces Fundraising and Conversion of Loan Notes

  3/12/2009

• ReNeuron Licenses Stem Cell Line To BioFocus DPI For Huntington’s Disease

  1/26/2009

• ReNeuron Clarifies Press Comments

  1/21/2009

• ReNeuron To Launch Pioneering Stem Cell Trial

  1/20/2009

• ReNeuron Interim Results For The Six Months Ended 30 September 2008

  12/1/2008

• ReNeuron To Present Key Safety Data At Leading European Molecular Biology Scientific Conference

  11/14/2008

• ReNeuron Announces New Data Regarding its ReNcell® Neural Stem Cell Lines

  7/15/2008

• ReNeuron to Present at International Society for Stem Cell Research Conference

  6/11/2008

• ReNeuron Welcomes UK Government Vote on Embryology Bill

  5/21/2008

• ReNeuron Says Receives U.S. Patent Grant Notice for ReN002 Diabetes Programme

  5/21/2008

• ReNeuron Provides IND Regulatory Update

  2/1/2008

• ReNeuron Welcomes Stem Cell Breakthrough

  11/21/2007

• ReNeuron to Present Positive Pre-Clinical Data Concerning its ReN005 Stem Cell Line for Huntington's Disease

  10/19/2007

• ReNeuron Stem Cell Stroke Therapy Successfully Completes Pre-Clinical Trials

  9/6/2007

• ReNeuron Release: Preliminary Results for the Year Ended 31 March 2007

  6/27/2007

• ReNeuron Says Scientists Generate Pancreatic Cell Lines to Treat Diabetes

  6/22/2007

• ReNeuron Announces New Data Concerning its ReNcell® Neural Stem Cell Lines

  5/31/2007

• ReNeuron Agrees Collaboration Deal to Develop Stem Cell Expansion Technology

  5/18/2007

• ReNeuron Welcomes EU Parliament Decision on Advanced Therapies Regulation

  4/25/2007

• ReNeuron Gains Revenue-Share on New Cell Line Patent

  2/26/2007